Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation-Reference-Cited by-同舟云学术

Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation

Published:2017-07-12 Issue:9 Volume:16 Page:1051-1062
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Rivera-Caravaca José Miguel¹²^ORCID,Esteve-Pastor María Asunción¹³,Roldán Vanessa²,Marín Francisco³,Lip Gregory Y.H.¹⁴

Affiliation:

1. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

2. Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain

3. Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain

4. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2017.1351542

Reference123 articles.

1. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Living on Oral Anticoagulants: Duke Anticoagulation Satisfaction Scale Results;Journal of Clinical Medicine;2023-12-08

2. Adherence to oral anticoagulation measured by electronic monitoring in a Belgian atrial fibrillation population;Clinical Research in Cardiology;2023-07-27

3. Persistence and Adherence to Cardiovascular Medicines in Australia;Journal of the American Heart Association;2023-07-04

4. Anticoagulation under-utilization in atrial fibrillation patients is responsible for a large proportion of strokes requiring endovascular therapy;Journal of Stroke and Cerebrovascular Diseases;2023-03

5. Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19;Current Medical Research and Opinion;2022-08-30